Psychometric assessment of somatic symptoms experiences instrument based on DSM-5

Author(s):
sohrab amirisohrab amiri,*, Yosef JamaliYosef Jamali

Koomesh:Vol. 20, issue 4; 699-704
Published online:Mar 29, 2018
Article type:Research Article
Received:Nov 01, 2016
Accepted:Mar 07, 2018
How to Cite:amiri S, Jamali Y. Psychometric assessment of somatic symptoms experiences instrument based on DSM-5. koomesh. 2018;20(4):e153014. doi:

Abstract

References

  • 1.
    Hanel G, Henningsen P, Herzog W, Sauer N, Schaefert R, Szecsenyi J, et al. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res 2009; 67: 189-197.
  • 2.
    Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903-910.
  • 3.
    Witthft M, Hiller W. Psychological approaches to origins and treatments of somatoform disorders. Annu Rev Clin Psychol 2010; 6: 257-283.
  • 4.
    American Psychiatric Association. Diagnosticand Statistical Manual of Mental Disorders DSM-5. 5th ed. Washington, D.C.: American Psychiatric Publishing; 2013.
  • 5.
    Voigt K, Wollburg E, Weinmann N, Herzog A, Meyer B, Langs G, et al. Predictive validity and clinical utility of DSM-5 somatic symptom disorder-comparison with DSM-IV somatoform disorders and additional criteria for consideration. J Psychosom Res November 2012; 73: 345-350.
  • 6.
    Rief W, Martin A. How to use the new DSM-5 Somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications. Annu Rev Clin Psychol 2014; 10: 339-367.
  • 7.
    Herzog A, Voigt K, Meyer B, Wollburg E, Weinmann N, Langs G, Lwe B. Psychological and interactional characteristics of patients with somatoform disorders: validation of the somatic symptoms experiences questionnaire (SSEQ) in a clinical psychosomatic population. J Psychosom Res 2015; 553-562.
  • 8.
    Creed F. The relationship between somatic symptoms, health anxiety, and outcome in medical out-patients. Psychiatr Clin North Am September 2011; 34: 545-564.
  • 9.
    Rief W, Mewes R, Martin A, Glaesmer H, Braehler E. Are psychological features useful in classifying patients with somatic symptoms? Psychosom Med 2010; 72: 648-655.
  • 10.
    Zijlema WL, Stolk RP, Lowe B, Rief W, White PD, Rosmalen JG. How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires. J Psychosom Res 2013; 74: 459-468.
  • 11.
    Gierk B, Kohlmann S, Kroenke K, Spangenberg L, Zenger M, Brahler E, et al. The Somatic Symptom Scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med March 2014; 174: 399-407.
  • 12.
    Gierk B, Kohlmann S, Toussaint A, Wahl I, Brunahl CA, Murray AM, et al. Assessing somatic symptom burden: a psychometric comparison of the patient health questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8). J Psychosom Res 2015; 78: 352-355.
  • 13.
    Klaus K, Mewes R. Assessment of the new DSM-5 diagnosis somatic symptom disorder (300.82). Verhaltenstherapie Verhaltensmedizin 2013; 34: 399-418.
  • 14.
    Pilowsky I. Dimensions of hypochondriasis. Br J Psychiatry 1967; 113: 89-93.
  • 15.
    Voigt K, Nagel A, Meyer B, Langs G, Braukhaus C, Lwe B. Towards positive criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psychosom Res 2010; 68: 403-414.
  • 16.
    Goldberg DP, Hillier VF. A scaled version of general health questionnaire. Psycho Med 1979; 9: 131-145.
  • 17.
    Hodiamont P, Peer N, Syben N. Epidemilogical aspects of psychiatric disorder iv a Dutch health area. Psycho Med 1978; 17: 495-505.
  • 18.
    Sodergren SC, Hyland ME. Qualitative phase in the development of the silver lining questionnaire. Qual Life Res 1997; 6: 365-373.
  • 19.
    Sodergren SC, Hyland ME. What are the positive consequences of illness? Psychol Health 2000; 15: 85-97.
  • 20.
    Hyland ME, Sodergren SC, Lewith GT. Chronic fatigue syndrome: the role of positivity to illness in chronic fatigue syndrome patients. J Health Psychol 2006; 11: 731-741.
  • 21.
    Jreskog KG, Srbom D. LISREL 8.80 for Windows [Computer Software]. Lincolnwood, IL: Scientific Software International, Inc. 2006.
  • 22.
    Brown TA. Confirmatory factor analysis for applied research. New York: Guilford Press. (2006).
  • 23.
    Schermelleh-Engel K, Moosbrugger H, Mller H. Evaluating the fit of structural equation models: Tests of significance and descriptive goodness of fit measures. Psychol Res 2003; 8: 23-74.
  • 24.
    Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate data analysis. Upper Saddle River, NJ: Pearson Prentice Hall; 2009.
  • 25.
    Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling A: Multidisciplinary J 1999; 6: 1-55.
  • 26.
    Tabachnick BG, Fidell LS. Using multivariate statistics (5th ed). Boston, MA: Pearson; 2007.##.

Similar Articles

23
Sep
2015

Reliability and Validity of the Farsi Version of the Somatosensory Amplification Scale

Alireza Aghayousefi,
Mohammad Oraki,
Narges Mohammadi,
Valiyollah Farzad,
Hammed Daghaghzadeh

Aghayousefi A, Oraki M, Mohammadi N, Farzad V, Daghaghzadeh H. Reliability and Validity of the Farsi Version of the Somatosensory Amplification Scale. Iran J Psychiatry Behav Sci. 2015;9(3):e233. doi: https://doi.org/10.17795/ijpbs-233

26
Aug
2023

Factor Structure and Psychometric Properties of the Substance Abuse Self-Stigma Scale in Patients with Substance Use Disorder

Mohammad Bagher Saberi Zafarghandi,
Farahnaz Mohammad Ghezel Ayagh,
Mohammad Darharaj,
Zahra Naderi Asl,
Mohadeseh Ghasemi

Saberi Zafarghandi MB, Mohammad Ghezel Ayagh F, Darharaj M, Naderi Asl Z, Ghasemi M. Factor Structure and Psychometric Properties of the Substance Abuse Self-Stigma Scale in Patients with Substance Use Disorder. koomesh. 2023;25(2):e154154. doi:

22
Feb
2023

Psychometric Evaluation of the Persian Version of Spontaneous Use of Imagery Scale in the Iranian Population

Yazdan Naderi Rajeh,
Behrooz Dolatshahi,
Abbas Pourshahbaz,
Mehran Zarghami

Naderi Rajeh Y, Dolatshahi B, Pourshahbaz A, Zarghami M. Psychometric Evaluation of the Persian Version of Spontaneous Use of Imagery Scale in the Iranian Population. Iran J Psychiatry Behav Sci. 2023;17(1):e123402. doi: https://doi.org/10.5812/ijpbs-123402

28
May
2016

Psychometric Properties of the Persian Version of the Social Anxiety - Acceptance and Action Questionnaire

Esmail Soltani,
Seyed Abdolmajid Bahrainian,
Abbas Masjedi Arani,
Ali Farhoudian,
Latif Gachkar

Soltani E, Bahrainian SA, Masjedi Arani A, Farhoudian A, Gachkar L. Psychometric Properties of the Persian Version of the Social Anxiety - Acceptance and Action Questionnaire. Iran J Psychiatry Behav Sci. 2016;10(2):e3753. doi: https://doi.org/10.17795/ijpbs.3753

12
Jul
2022
Zahedan J Res Med Sci.

Development and Validation of COVID-19 Stress Scale (CSS) in an Iranian Non-clinical Population

Roghieh Nooripour,
Nikzad Ghanbari,
Laurel E. Radwin,
Simin Hosseinian,
Peyman Hassani-Abharian,
Mohsen Hosseinbor
,et al.

Nooripour R, Ghanbari N, Radwin LE, Hosseinian S, Hassani-Abharian P, et al. Development and Validation of COVID-19 Stress Scale (CSS) in an Iranian Non-clinical Population. Zahedan J Res Med Sci. 2022;24(3):e118719. doi: https://doi.org/10.5812/zjrms-118719

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC